Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis

BACKGROUND: The assessment of treatment response in idiopathic pulmonary fibrosis (IPF) is complicated by the variable clinical course. We examined the variability in the rate of disease progression and evaluated the effect of continued treatment with pirfenidone in patients who experienced meaningf...

全面介紹

Na minha lista:
書目詳細資料
發表在:Thorax
Main Authors: Nathan, Steven D, Albera, Carlo, Bradford, Williamson Z, Costabel, Ulrich, du Bois, Roland M, Fagan, Elizabeth A, Fishman, Robert S, Glaspole, Ian, Glassberg, Marilyn K, Glasscock, Kenneth F, King, Talmadge E, Lancaster, Lisa, Lederer, David J, Lin, Zhengning, Pereira, Carlos A, Swigris, Jeffrey J, Valeyre, Dominique, Noble, Paul W, Wells, Athol U
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2016
主題:
Interstitial Lung Disease
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4862066/
https://ncbi.nlm.nih.gov/pubmed/26968970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/thoraxjnl-2015-207011
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍